GIANNELLI, FRANCESCA
GIANNELLI, FRANCESCA
Alterazioni del sistema pPAF-AH/PAF in pazienti con infezione cronica da HCV
2003 P. Caini; C. Tosti Guerra; F. Giannelli; G. Buzzelli; E. Di Pietro; C. Giannini; L. Gragnani; V. Solazzo; M. Monti; G. Laffi; P. Gentilini; A.L. Zignego
Analysis of HCV persistence in patients with sustained virological response
2006 C. Giannini; A. Petrarca; U. Arena; M. Monti; V. Solazzo; F. Giannelli; P. Caini; G. La Villa; G. Laffi; P. Gentilini; A.L. Zignego
Association between HCV infection and monoclonal gammopathy (MG): A putative role for genotype 2a?
1996 Andreone P; Zignego AL; Cursaro C; Gramenzi A; Boni P; Cappelletti O; Giannini C; Giannelli F; Bernardi M; Gentilini P; Gasbarrini G
Association between mixed cryoglobulinemia, translocation (14;18), and persistence of occult HCV lymphoid infection after treatment
2006 C. Giannini; F. Giannelli; A.L. Zignego
Bcl-2 rearranged B cell clones in chronic HCV infection: a possible factor negatively influencing the virological response to treatment
2002 F. Giannelli; M. Monti; P. Caini; S. Moscarella; R.G. Romanelli; C. Giannini; L. Gragnani; G. La Villa; G. Laffi; P. Gentilini; A.L. Zignego
BCL-2 recombination and overexpression in HCV-related mixed cryoglobulinemia patients.
1999 A.L. Zignego; C. Ferri; F. Giannelli; A. Mazzocca; G. Longombardo; G. Porciello; P. Fadda; M.E. Marrocchi; S. Moscarella; P. Gentilini
Bcl-2 Recombination and Overexpression in HCV-related Mixed Cryoglobulinemia Patients.
1999 A.L. Zignego; C. Ferri; F. Giannelli; A. Mazzocca; G Longombardo; G. Porciello; P. Fadda; ME Marrocchi; S. Moscarella; P. Gentilini.
Behaviour of sustained responders to anti-HCV treatment: may HCV infection be eradicated?
2005 A. Petrarca; U. Arena; C. Giannini; M. Monti; V. Solazzo; F. Giannelli; P. Caini; G. La Villa; G. Laffi; A.L. Zignego
COMBINED PRESENCE OF HCVRNA SEQUENCES AND T(14;18) (q32;q21) TRANSLOCATION IN PBMC FROM PATIENTS WITH CHRONIC HCV INFECTION.
2000 A. Mazzocca; F. Giannelli; R.G. Romanelli; S. Moscarella; P. Caini; C. Giannini; M. Monti; G. La Villa; G. Laffi. P. Gentilini; A.L. Zignego.
Combined presence of HCVRNA sequences and t(14;18) (q32;q21) translocation in PBMC from patients with chronic HCV infection
2000 A. Mazzocca; F. Giannelli; R.G. Romanelli; S. Moscarella; P. Caini; C. Giannini; M. Monti; G. La Villa; G. Laffi; P. Gentilini; A.L. Zignego
Effect of antiviral treatment in patients with chronic HCV infection and t(14;18) translocation
2003 F. Giannelli; S. Moscarella; C. Giannini; P. Caini; M. Monti; L. Gragnani; R.G. Romanelli; G. Buzzelli; G. Laffi; G. La Villa; P. Gentilini; A.L. Zignego
Effect of antiviral treatment on the prevalence of BCL-2 recombination in HCV infected patients
1999 A.Mazzocca; M.E. Marrocchi; G. Careccia; F. Giannelli; R.G. Romanelli; S. Moscarella; C. Giannini; P. Gentilini; A.L. Zignego
Effect of chronic hepatitis C virus infection on inflammatory lipid mediators
2007 C. Tosti Guerra; P. Caini; C. Giannini; F. Giannelli; L. Gragnani; A. Petrarca; V. Solazzo; M. Monti; G. Laffi; A.L. Zignego
Efficacia del trattamento antivirale nell’indurre la regressione di cloni B cellulari alberganti la traslocazione t(14;18) nell’infezione cronica da virus C dell’epatite (HCV).
2001 GIANNELLI F; MOSCARELLA S; ROMANELLI RG; MONTI M; GIANNINI C; CAINI P; GRAGNANI L; LAFFI G; GENTILINI P; ZIGNEGO AL
Frequency of bcl-2 rearrangement in patients with mixed cryoglobulinemia and HCV-positive liver diseases
1997 A.L. Zignego; F. Giannelli; M.E. Marrocchi; C. Giannini; P. Gentilini; F. Innocenti; C. Ferri
HCV core protein expression in human B cell lines does not significantly modify proliferative and apoptosis pathways
2001 C. Giannini; P. Caini; F. Fontana; F. Giannelli; N. Delhem; C. Brechot; A.L. Zignego
HCV core protein expression in human B cell lines does not significantly modify proliferative and apoptosis pathways
2002 P. Caini; C. Giannini; F. Giannelli; C. Brechot; A.L. Zignego
HCV core protein expression in human B cell lines does not significantly modify proliferative and apoptosis pathways.
2002 C GIANNINI; P CAINI; F GIANNELLI; F FONTANA; N DELHEM; C BRÉCHOT; A.L. ZIGNEGO
HCV infection in B-cell non-Hodgkin’s lymphoma.
1995 A.L. ZIGNEGO; C FERRI; C GIANNINI; F CARACCIOLO; M MONTI; L LA CIVITA; G CARECCIA; G LONGOMBARDO; F GIANNELLI; G BELLESI; F INNOCENTI; F GRECO; C MAZZARO; G PASERO; P GENTILINI
Hepatitis C virus as a lymphotropic agent: Evidence and pathogenetic implications
1995 A.L. Zignego; C. Ferri; M. Monti; L. La Civita; C. Giannini; G. Careccia; F. Giannelli; G. Pasero; S. Bombardieri; P. Gentilini
Titolo | Data di pubblicazione | Autore(i) | File |
---|---|---|---|
Alterazioni del sistema pPAF-AH/PAF in pazienti con infezione cronica da HCV | 2003 | P. Caini; C. Tosti Guerra; F. Giannelli; G. Buzzelli; E. Di Pietro; C. Giannini; L. Gragnani; V. Solazzo; M. Monti; G. Laffi; P. Gentilini; A.L. Zignego | |
Analysis of HCV persistence in patients with sustained virological response | 2006 | C. Giannini; A. Petrarca; U. Arena; M. Monti; V. Solazzo; F. Giannelli; P. Caini; G. La Villa; G. Laffi; P. Gentilini; A.L. Zignego | |
Association between HCV infection and monoclonal gammopathy (MG): A putative role for genotype 2a? | 1996 | Andreone P; Zignego AL; Cursaro C; Gramenzi A; Boni P; Cappelletti O; Giannini C; Giannelli F; Bernardi M; Gentilini P; Gasbarrini G | |
Association between mixed cryoglobulinemia, translocation (14;18), and persistence of occult HCV lymphoid infection after treatment | 2006 | C. Giannini; F. Giannelli; A.L. Zignego | |
Bcl-2 rearranged B cell clones in chronic HCV infection: a possible factor negatively influencing the virological response to treatment | 2002 | F. Giannelli; M. Monti; P. Caini; S. Moscarella; R.G. Romanelli; C. Giannini; L. Gragnani; G. La Villa; G. Laffi; P. Gentilini; A.L. Zignego | |
BCL-2 recombination and overexpression in HCV-related mixed cryoglobulinemia patients. | 1999 | A.L. Zignego; C. Ferri; F. Giannelli; A. Mazzocca; G. Longombardo; G. Porciello; P. Fadda; M.E. Marrocchi; S. Moscarella; P. Gentilini | |
Bcl-2 Recombination and Overexpression in HCV-related Mixed Cryoglobulinemia Patients. | 1999 | A.L. Zignego; C. Ferri; F. Giannelli; A. Mazzocca; G Longombardo; G. Porciello; P. Fadda; ME Marrocchi; S. Moscarella; P. Gentilini. | |
Behaviour of sustained responders to anti-HCV treatment: may HCV infection be eradicated? | 2005 | A. Petrarca; U. Arena; C. Giannini; M. Monti; V. Solazzo; F. Giannelli; P. Caini; G. La Villa; G. Laffi; A.L. Zignego | |
COMBINED PRESENCE OF HCVRNA SEQUENCES AND T(14;18) (q32;q21) TRANSLOCATION IN PBMC FROM PATIENTS WITH CHRONIC HCV INFECTION. | 2000 | A. Mazzocca; F. Giannelli; R.G. Romanelli; S. Moscarella; P. Caini; C. Giannini; M. Monti; G. La Villa; G. Laffi. P. Gentilini; A.L. Zignego. | |
Combined presence of HCVRNA sequences and t(14;18) (q32;q21) translocation in PBMC from patients with chronic HCV infection | 2000 | A. Mazzocca; F. Giannelli; R.G. Romanelli; S. Moscarella; P. Caini; C. Giannini; M. Monti; G. La Villa; G. Laffi; P. Gentilini; A.L. Zignego | |
Effect of antiviral treatment in patients with chronic HCV infection and t(14;18) translocation | 2003 | F. Giannelli; S. Moscarella; C. Giannini; P. Caini; M. Monti; L. Gragnani; R.G. Romanelli; G. Buzzelli; G. Laffi; G. La Villa; P. Gentilini; A.L. Zignego | |
Effect of antiviral treatment on the prevalence of BCL-2 recombination in HCV infected patients | 1999 | A.Mazzocca; M.E. Marrocchi; G. Careccia; F. Giannelli; R.G. Romanelli; S. Moscarella; C. Giannini; P. Gentilini; A.L. Zignego | |
Effect of chronic hepatitis C virus infection on inflammatory lipid mediators | 2007 | C. Tosti Guerra; P. Caini; C. Giannini; F. Giannelli; L. Gragnani; A. Petrarca; V. Solazzo; M. Monti; G. Laffi; A.L. Zignego | |
Efficacia del trattamento antivirale nell’indurre la regressione di cloni B cellulari alberganti la traslocazione t(14;18) nell’infezione cronica da virus C dell’epatite (HCV). | 2001 | GIANNELLI F; MOSCARELLA S; ROMANELLI RG; MONTI M; GIANNINI C; CAINI P; GRAGNANI L; LAFFI G; GENTILINI P; ZIGNEGO AL | |
Frequency of bcl-2 rearrangement in patients with mixed cryoglobulinemia and HCV-positive liver diseases | 1997 | A.L. Zignego; F. Giannelli; M.E. Marrocchi; C. Giannini; P. Gentilini; F. Innocenti; C. Ferri | |
HCV core protein expression in human B cell lines does not significantly modify proliferative and apoptosis pathways | 2001 | C. Giannini; P. Caini; F. Fontana; F. Giannelli; N. Delhem; C. Brechot; A.L. Zignego | |
HCV core protein expression in human B cell lines does not significantly modify proliferative and apoptosis pathways | 2002 | P. Caini; C. Giannini; F. Giannelli; C. Brechot; A.L. Zignego | |
HCV core protein expression in human B cell lines does not significantly modify proliferative and apoptosis pathways. | 2002 | C GIANNINI; P CAINI; F GIANNELLI; F FONTANA; N DELHEM; C BRÉCHOT; A.L. ZIGNEGO | |
HCV infection in B-cell non-Hodgkin’s lymphoma. | 1995 | A.L. ZIGNEGO; C FERRI; C GIANNINI; F CARACCIOLO; M MONTI; L LA CIVITA; G CARECCIA; G LONGOMBARDO; F GIANNELLI; G BELLESI; F INNOCENTI; F GRECO; C MAZZARO; G PASERO; P GENTILINI | |
Hepatitis C virus as a lymphotropic agent: Evidence and pathogenetic implications | 1995 | A.L. Zignego; C. Ferri; M. Monti; L. La Civita; C. Giannini; G. Careccia; F. Giannelli; G. Pasero; S. Bombardieri; P. Gentilini |